The global next generation sequencing market size is expected to reach USD 23.7 billion by 2027, expanding at a CAGR of 11.7%, according to a new report by Grand View Research, Inc. Numerous advantages offered by high throughput sequencing over other genetic technologies such as sanger-seq and microarray is one of the key driving forces of the market for Next Generation Sequencing (NGS). Furthermore, increasing availability of low input DNA sampling methods that decrease the overall operational costs is anticipated to accelerate the use of next generation sequencing across various research and clinical applications.
Technology offered by New England Biolabs that employs magnetic beads in the template assembly process is anticipated to significantly improve the sample preparation protocols for next generation sequencing. Furthermore, recent technological advancements such as the use of Laboratory Information Management System (LIMS) for genome library automation allow next generation sequencing in a single day at a reasonable cost. These advancements are anticipated to proliferate the number of users of next generation sequencing over the forecast period.
Request a sample Copy of the Global Next Generation Sequencing Market Research Report @ www.grandviewresearch.com/industry-analysis/next-generation-sequencing-market/request/rs1
This technology has captured the attention of several companies and investors operating across various domains including basic research, drug discovery and development, reproductive health, and consumer genomics. In addition, the plummeting cost and the added value of next generation sequencing data over conventional ones is anticipated to positively impact the diversification of this technology in other clinical areas, resulting into a lucrative revenue growth.
Further key findings from the report suggest:
Have Any Query? Ask Our Experts @ www.grandviewresearch.com/inquiry/1496/ibb
Grand View Research has segmented the global next generation sequencing market based on application, technology, workflow, end use, and region:
NGS Application Outlook (Revenue, USD Million, 2016 – 2027)
NGS Technology Outlook (Revenue, USD Million, 2016 – 2027)
NGS Workflow Outlook (Revenue, USD Million, 2016 – 2027)
NGS End-use Outlook (Revenue, USD Million, 2016 – 2027)
NGS Regional Outlook (Revenue, USD Million, 2016 – 2027)
Browse Related Category @
Clinical Oncology Next Generation Sequencing Market – www.grandviewresearch.com/industry-analysis/clinical-oncology-next-generation-sequencing-ngs-market
Short-read Sequencing Market – www.grandviewresearch.com/industry-analysis/short-read-sequencing-market
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research Guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Media ContactCompany Name: Grand View Research, Inc.Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.Email: Send EmailPhone: 1-415-349-0058, Toll Free: 1-888-202-9519Address:201, Spear Street, 1100 City: San FranciscoState: CaliforniaCountry: United StatesWebsite: https://www.grandviewresearch.com/industry-analysis/next-generation-sequencing-market